Literature DB >> 7251289

1,25-dihydroxycholesterol treatment of long-term haemodialysed patients with renal osteodystrophy.

L Váry.   

Abstract

Renal osteodystrophy still poses major problems in the management of chronic renal failure, though it had been extensively studied over the last years. The present therapeutic possibilities - massive-dose vitamin D, aluminium hydroxide and supplementary Ca-intake, administration of active vitamin D metabolites - are discussed in the light of personal observations.

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7251289     DOI： 10.1007/bf02217143

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN： 0301-1623            Impact factor:   2.370


  8 in total

1.  [Comparative morphological and radiological course observations on the skeletal system of dialysis patients].

Authors:  R Giertler; F Trux; B Pfann; U Scheler; H Meister; I Grossmann
Journal:  Z Urol Nephrol       Date:  1976-12

2.  [Enteral absorption of Ca-47 in uremic dialyzed patients].

Authors:  B Keszthelyi; A Tóth; S Novotny; L Váry; S Köves; F Balogh; T Past; T Jávor
Journal:  Orv Hetil       Date:  1976-04-04       Impact factor: 0.540

3.  [The use of photon absorptiometry in renal osteodystrophy (author's transl)].

Authors:  A Samizadeh; H Loew; G Busch; H Müller; H Losse
Journal:  Klin Wochenschr       Date:  1977-10-15

4.  1alpha-hydroxychloecalciferol treatment of long-term hemodialyzed patients. Effects on mineral metabolism, bone mineral content and bone morphometry.

Authors:  H E Nielsen; F Melsen; M S Christensen; H E Hansen; P Rodbro; A Johannsen
Journal:  Clin Nephrol       Date:  1977-10       Impact factor: 0.975

5.  Changes in histologic and biochemical indexes of bone turnover after bilateral nephrectomy in patients on hemodialysis. Evidence for a possible role of endogenous calcitonin.

Authors:  J A Kanis; M Earnshaw; G Heynen; J G Ledingham; D O Oliver; G G Russell; C G Woods; P Franchimont; S Gaspar
Journal:  N Engl J Med       Date:  1977-05-12       Impact factor: 91.245

6.  [Parathyroid adenoma (tertiary hyperparathyroidosis) in uremic patients treated by chronic hemodialysis].

Authors:  J Szúcs; E Molnár; A Hamvas
Journal:  Orv Hetil       Date:  1978-01-15       Impact factor: 0.540

7.  [Analysis of the mineral content in the radius of healthy adults].

Authors:  G István; K István; H Tamara; S János; H István
Journal:  Orv Hetil       Date:  1978-03-19       Impact factor: 0.540

8.  Effects of high dialysate calcium concentration on bone remodelling, serum biochemistry, and parathyroid hormone in patients with renal osteodystrophy.

Authors:  T Drüeke; P J Bordier; N K Man; P Jungers; P Marie
Journal:  Kidney Int       Date:  1977-04       Impact factor: 10.612
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.